Unlocking the potential of organopalladium complexes for high-grade serous ovarian cancer therapy

This is the authors' abstract. We don't add key points for this paper.

mouse models, which demonstrate its remarkable efficacy with surprisingly low collateral toxicity even at high dosages. Moreover, this class of compounds appears to operate through a ferroptotic mechanism, thus representing the first such example for an organopalladium compound.